Camel Group Co., Ltd. Financial Data
Consolidated
Consolidated Balance Sheet (B/S)(in CNY millions)
| FY ended Dec. 31, 2025 | FY ended Dec. 31, 2024 | FY ended Dec. 31, 2023 | FY ended Dec. 31, 2022 | FY ended Dec. 31, 2021 | |
| Current assets | 8,723.29 | 8,233.90 | 7,460.78 | 6,924.17 | 6,261.84 |
| Illiquid assets | 6,943.75 | 6,762.21 | 6,555.18 | 6,578.44 | 6,675.36 |
| Total assets | 15,667.04 | 14,996.11 | 14,015.95 | 13,502.61 | 12,937.20 |
| Current liabilities | 3,562.79 | 4,290.34 | 4,060.98 | 3,814.06 | 3,073.96 |
| Illiquid debts | 1,875.13 | 975.06 | 536.93 | 565.01 | 1,082.60 |
| Total liabilities | 5,437.92 | 5,265.40 | 4,597.91 | 4,379.07 | 4,156.56 |
| Capital | 1,173.15 | 1,173.15 | 1,173.15 | 1,173.15 | 1,173.15 |
| Capital reserve | 1,718.75 | 1,707.52 | 1,707.27 | 1,746.37 | 1,761.26 |
| Profit reserve | 585.07 | 585.07 | 585.07 | 585.07 | 527.63 |
| Backlog profit | 6,165.14 | 5,667.52 | 5,370.30 | 5,032.49 | 4,878.00 |
| Minority stock holders' equity | 147.63 | 175.55 | 156.47 | 157.51 | 293.68 |
| Total stockholders' equity | 10,229.12 | 9,730.71 | 9,418.05 | 9,123.55 | 8,780.64 |
| Total Liabilities and shareholders' equity | 15,667.04 | 14,996.11 | 14,015.95 | 13,502.61 | 12,937.20 |
Consolidated Profit and Loss Statement (in CNY millions)
| FY ended Dec. 31, 2025 | FY ended Dec. 31, 2024 | FY ended Dec. 31, 2023 | FY ended Dec. 31, 2022 | FY ended Dec. 31, 2021 | |
| Sales | 16,303.22 | 15,592.20 | 14,078.85 | 13,425.36 | 12,403.45 |
| Operating profit | 958.53 | 700.73 | 710.73 | 483.87 | 926.97 |
| Gross profit | 948.90 | 695.31 | 686.23 | 477.08 | 922.10 |
| Net profit | 848.86 | 633.06 | 572.59 | 455.96 | 847.36 |
Consolidated Cash Flow (in CNY millions)
| FY ended Dec. 31, 2025 | FY ended Dec. 31, 2024 | FY ended Dec. 31, 2023 | FY ended Dec. 31, 2022 | FY ended Dec. 31, 2021 | |
| Cash flows from operating activities | 828.82 | 619.07 | 690.93 | 245.84 | 765.22 |
| Cash flows from investing activities | (1,460.26) | 77.21 | (416.35) | 459.24 | 65.39 |
| Cash flows from financing activities | (512.30) | (21.99) | (206.13) | (490.73) | (351.07) |
| Gains (losses) from exchange-rate translation | 44.17 | (2.80) | 3.62 | 24.57 | (8.75) |
| Increases (decreases) in cash and cash equivalents | (1,099.59) | 671.49 | 72.07 | 238.92 | 470.80 |
| Cash and cash equivalent at the beginning of the term | 2,141.15 | 1,469.66 | 1,397.60 | 1,158.68 | 687.88 |
| Cash and cash equivalents at the term-end | 1,041.57 | 2,141.15 | 1,469.66 | 1,397.60 | 1,158.68 |
Non-Consolidated
Unconsolidated balance sheet (B/S) (in CNY millions)
| FY ended Dec. 31, 2025 | FY ended Dec. 31, 2024 | FY ended Dec. 31, 2023 | FY ended Dec. 31, 2022 | FY ended Dec. 31, 2021 | |
| Current assets | 4,898.68 | 5,807.70 | 4,549.34 | 4,205.85 | 3,815.96 |
| Illiquid assets | 7,742.62 | 7,672.70 | 7,296.78 | 6,737.94 | 6,592.36 |
| Total assets | 12,641.30 | 13,480.40 | 11,846.12 | 10,943.79 | 10,408.32 |
| Current liabilities | 2,853.63 | 3,476.04 | 3,341.30 | 3,288.70 | 3,475.36 |
| Illiquid debts | 355.38 | 445.26 | 154.831 | 165.76 | 138.98 |
| Total liabilities | 3,209.01 | 3,921.29 | 3, 496.14 | 3,454.46 | 3,614.35 |
| Capital | 1,173.15 | 1,173.15 | 1,173.15 | 1,173.15 | 1,173.15 |
| Capital reserve | 1,782.30 | 1,777.69 | 1,777.45 | 1,775.41 | 1,788.34 |
| Profit reserve | 586.57 | 586.57 | 586.57 | 586.57 | 529.13 |
| Backlog profit | 5,448.44 | 5,579.87 | 4,370.42 | 3,511.95 | 3,135.12 |
| Total stockholders' equity | 9,432.29 | 9,559.11 | 8,349.99 | 7,489.32 | 6,793.97 |
| Total Liabilities and shareholders' equity | 12,641.30 | 13,480.40 | 11,846.12 | 10,943.79 | 10,408.32 |
Unconsolidated cash flow (in CNY millions)
| FY ended Dec. 31, 2025 | FY ended Dec. 31, 2024 | FY ended Dec. 31, 2023 | FY ended Dec. 31, 2022 | FY ended Dec. 31, 2021 | |
| Sales | 81.56 | 134.35 | 145.97 | 156.18 | 60.09 |
| Operating profit | 207.72 | 1,515.23 | 1,089.26 | 655.79 | 583.50 |
| Gross profit | 202.96 | 1,513.78 | 1,082.92 | 658.11 | 581.13 |
| Net profit | 208.79 | 1,526.19 | 1,093.10 | 692.36 | 588.04 |
Unconsolidated profit and loss statement (in CNY millions)
| FY ended Dec. 31, 2025 | FY ended Dec. 31, 2024 | FY ended Dec. 31, 2023 | FY ended Dec. 31, 2022 | FY ended Dec. 31, 2021 | |
| Cash flows from operating activities | 1,734.16 | 33.34 | (214.31) | (1,373.42) | 101.52 |
| Cash flows from investing activities | (1,046.39) | 1,520.54 | 730.06 | 1,424.68 | 554.44 |
| Cash flows from financing activities | (2,053.94) | (772.66) | (515.52) | 272.61 | (343.28) |
| Gains (losses) from exchange-rate translation | (1.58) | 1.33 | 0.76 | 5.29 | (5.79) |
| Increases (decreases) in cash and cash equivalents | (1,367.74) | 782.56 | 1.00 | 329.16 | 306.89 |
| Cash and cash equivalent at the beginning of the term | 1,621.18 | 838.62 | 837.62 | 508.46 | 201.58 |
| Cash and cash equivalents at the term-end | 253.44 | 1,621.18 | 838.62 | 837.62 | 508.46 |



Japan
USA
Mexico
Germany
China (Shanghai)
Thailand
India